pharmaphorum

MARCH 29, 2017

Pharmacists are highly trained healthcare professionals who have a deep understanding of medicines and daily contact with patients and consumers. This puts them in a unique position in terms of being able to maximise the benefits that patients get from their medicines – however, healthcare systems and pharmaceutical companies frequently overlook this potential.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Patient Care 52

Med Ed 101

MARCH 29, 2017

Below is a case scenario where clonidine is being used in the elderly. Clonidine is on the Beer’s list of potentially inappropriate medications in the elderly. Let’s break it down. JS is an 87 year old female with a past medical history of hypertension, dementia, depression, weight loss, GERD, osteoarthritis, hypothyroidism, anxiety and anemia.

40

40

Med Ed 101

MARCH 26, 2017

The omeprazole clopidogrel interaction has always been a challenging one to know precisely what to do. Since a significant number of media reports came out in 2010 due to information regarding the omeprazole and clopidogrel interaction, it has been hotly debated as to how to manage this drug interaction. The FDA also had a somewhat […]. The post Clinical Conundrum: Omeprazole Clopidogrel Interaction – Four Considerations appeared first on Med Ed 101.

FDA 40

FDA 40

Med Ed 101

MARCH 22, 2017

A 79 year old female has a medical history of hypertension, atrial fibrillation, falls with orthostatic hypotension, osteoarthritis, depression and anxiety, constipation, COPD and insomnia. Her current chief complaints are shortness of breath, edema, and falls. Her current medication list includes: Warfarin (goal INR 2-3) Metoprolol tartrate 25 mg BID Losartan 100 mg daily Lasix […].

40

40

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Med Ed 101

MARCH 19, 2017

An 81 year old male presents with worsening confusion over a period of about 3-6 months. The primary provider is considering an Rx for Aricept as she feels that this is Alzheimer’s dementia in the mild to moderate stage. What do we do as pharmacists? One of the major things we can help with when […]. The post Amitriptyline and Dementia appeared first on Med Ed 101.

40

40

Med Ed 101

MARCH 12, 2017

An 86 year old male is having a difficult time with weakness and falls. With weakness and falls, we always need to take a good hard look at blood pressure to make sure we aren’t causing drug induced orthostasis. There are also times when family feels like he is very sleepy. He also had mild […]. The post Drug Induced Orthostasis appeared first on Med Ed 101.

40

40

Med Ed 101

MARCH 5, 2017

Do you ever feel like you can’t get ahead when it comes to knowing and remembering things? It hit me hard the other day. New drugs are coming out all the time, new guideline changes, new studies on drug interactions, safety alerts, and on and on. I feel like I can’t keep up and it’s […]. The post Trintellix Brintellix – The Struggle to Keep Up is Real appeared first on Med Ed 101.

40

40

Med Ed 101

MARCH 1, 2017

A 62 year old is taking the following medications Enalapril 10 mg daily Diclofenac 50 mg twice daily Allopurinol 200 mg daily Indomethacin 25 mg TID prn Azathioprine 50 mg twice daily Ranitidine 150 mg at night Lansoprazole 15 mg every morning Aspirin 81 mg daily Metoprolol 25 mg twice daily Simvastatin 20 mg daily […]. The post Medication List Review – Azathioprine Allopurinol Interation appeared first on Med Ed 101.

40

40

pharmaphorum

MARCH 10, 2017

2017 is once again a year of significant change for pharma market access in Europe, with affordability on the agenda for almost every country in the region. There is a move toward greater collaboration in health technology assessment and more transparency between countries for pricing, therapeutic protocols and and details of negotiations with drug manufacturers.

52

52